Eli Lilly and Company

Eli Lilly and Company is one of the world’s leading research-driven pharmaceutical companies, dedicated to discovering, developing, manufacturing, and commercializing innovative medicines that improve patient outcomes. Founded in 1876 by Colonel Eli Lilly and headquartered in Indianapolis, Indiana, USA, the company has built a global reputation for scientific excellence and medical innovation. Today, Lilly operates in more than 120 countries and focuses on therapeutic areas including diabetes, obesity, oncology, immunology, neuroscience, pain management, and autoimmune diseases.

The company has become a global leader in diabetes and obesity treatments while continuing to expand its pipeline in Alzheimer’s disease, cancer therapies, dermatology, and rare diseases. Lilly combines biotechnology, genomics, artificial intelligence, digital health technologies, and precision medicine to accelerate research and drug development. Its extensive network of research centers and advanced manufacturing facilities supports the delivery of high-quality medicines to millions of patients worldwide.

Eli Lilly places strong emphasis on scientific integrity, sustainability, patient access, and responsible manufacturing practices. Through collaborations with biotechnology companies, universities, healthcare providers, and research organizations, the company continues to advance innovative therapies that address significant unmet medical needs. With nearly 150 years of pharmaceutical heritage and continuous investment in next-generation healthcare solutions, Eli Lilly remains one of the world’s most influential pharmaceutical manufacturers.